EUMCA Executive Board
The EUMCA Executive Board, led by our Chairman, Professor Trevor Jones CBE, works collaboratively with the EUMCA management team to help develop the operational excellence of the organisation, and its priorities and work programme.
Members of the Executive Board include our Chairman, Professor Trevor Jones CBE and the 9 heads of our Founding Member Companies.
EUMCA Management Team
Prof Trevor M Jones CBE FMedSci
Chairman
PhD DSc Hon FRCP FBPhS FRSM FRSC FLSW
Professor Jones is an accomplished and distinguished scientist, policy expert and businessman who, in the course of his career, has made a central contribution to global health through his scientific research and development output. As Group R&D Director at The Wellcome Foundation Ltd he was responsible for the development of AZT, Zovirax, Lamictal, Malarone and other medicines. He was a Director of Allergan Inc. (USA), and Director General of the Association of the British Pharmaceutical Industry (ABPI).
Professor Jones served for 12 years as a member of the UK Government Regulatory Agency Medicines Commission and as Chairman of the UK Government Advisory Group on Genetics Research. Currently he is Director of the Life Sciences investment company Arix Bioscience plc, of the Oxford based Drug Discovery Company e-Therapeutics plc and of Respiratory Innovation Wales Ltd. Professor Jones is also a visiting professor at King’s College, London and was appointed to the World Health Organization Commission on Intellectual Property Rights, Innovation and Public Health.
Sita Schubert - General Secretary
Attorney at Law – Life Science and Economy Compliance, HealthCare
International Consultancy/Healthcare Industry. Country Manager sigma-tau Germany Rare Disease Unit Global. Board of German/NRW Pharmaceutical Association.
Representative Chair(wo-)man of Pharma Code of Conduct Association. Founding Member of Healthcare Business Network “Female Leaders in Healthcare”
Keith Williams - Deputy General Secretary
More than 20 years Operational experience: General Management, Commercial, Sales & Marketing with Blue Chip companies (GSK, MSD, LEO, Lediant Biosciences).
Over 13 years experience managing and selling rare disease products and unlicensed medicines in UK, Ireland, Nordics and EU.
Established Leadiant Biosciences (EU rare disease business) in the UK
Former Director and Co-Founder of LogixX Pharma
Jeremy Morais - Medical Director
An experienced, GMC registered pharmaceutical physician with a successful track record working with rare disease, generics and innovator medicines in a broad range of therapy areas.
Extensive experience working in clinical development, medical affairs, pharmacovigilance, medical information and compliance functions and managing head office and field-based teams in medical.
An ABPI final signatory for over 16 years with an excellent track record of managing successful national, regional and global multidisciplinary teams. Involved in planning and executing clinical trial and medical affairs strategies as well as change management processes to meet organisational requirements.
Has a strong interest in medicinal cannabis and its applications in clinical situations
Penny Lukats - Communications Director
Over more than 20 years in public relations and marketing communications she has developed a number of specialities, among them a notable capacity for drawing compelling, illuminating stories from research and data.
A blend of analytical skills, creative flair and commercial acumen drives Penny’s success in creating multi-faceted campaigns that capture the attention of the media and target audiences.
Gudrun Köhler - Treasurer
Lisa Williams - Marketing Communications
Lucy Hand - Marketing Communications
Sita Schubert - General Secretary
Attorney at Law – Life Science and Economy Compliance, HealthCare
International Consultancy/Healthcare Industry. Country Manager sigma-tau Germany Rare Disease Unit Global. Board of German/NRW Pharmaceutical Association.
Representative Chair(wo-)man of Pharma Code of Conduct Association. Founding Member of Healthcare Business Network “Female Leaders in Healthcare”
Keith Williams - Deputy General Secretary
More than 20 years Operational experience: General Management, Commercial, Sales & Marketing with Blue Chip companies (GSK, MSD, LEO, Lediant Biosciences).
Over 13 years experience managing and selling rare disease products and unlicensed medicines in UK, Ireland, Nordics and EU.
Established Leadiant Biosciences (EU rare disease business) in the UK
Former Director and Co-Founder of LogixX Pharma with turnover >£6m
Jeremy Morais - Medical Director
An experienced, GMC registered pharmaceutical physician with a successful track record working with rare disease, generics and innovator medicines in a broad range of therapy areas.
Extensive experience working in clinical development, medical affairs, pharmacovigilance, medical information and compliance functions and managing head office and field-based teams in medical.
An ABPI final signatory for over 16 years with an excellent track record of managing successful national, regional and global multidisciplinary teams. Involved in planning and executing clinical trial and medical affairs strategies as well as change management processes to meet organisational requirements.
Currently working independently as a consultant pharmaceutical physician. Has a strong interest in medicinal cannabis and its applications in clinical situations
Penny Lukats - Communications Director
Over more than 20 years in public relations and marketing communications she has developed a number of specialities, among them a notable capacity for drawing compelling, illuminating stories from research and data.
A blend of analytical skills, creative flair and commercial acumen drives Penny’s success in creating multi-faceted campaigns that capture the attention of the media and target audiences.
Gudrun Köhler - Treasurer
Lucy Hand - Marketing Communications
Lisa Williams - Marketing Communications
Get in touch
Please submit your membership enquiry and our team will be in touch to discuss
Or call +32 233 90 281
Our Mission
In order to improve the life and health outcomes of patients across Europe, the EUMCA facilitates the development of national government healthcare policies that advocate for the ethical prescription of pharmaceutical-grade medicinal cannabis, and advance patient access to treatments
+32 233 90 281
info@eumca.org
EUMCA, Brussels, Belgium
